More Imugene Ltd news Imugene LtdASX: IMU Phase 1 onCARlytics Trial Doses First Intravenous Patient Feb 15, 2024 at 2:49 AM UTC · Issued by Imugene Ltd As issuedPlain English Imugene Ltd has released a press release. View Attachment
